Announcement on Convening the Q3 2025 Performance Briefing
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment
Announcement on Convening the Q3 2025 Performance Briefing
Filed with SSE ·
6ix hasn’t read this filing yet.
Jiangsu gdk Biotechnology Co., Ltd. on 6ix
Earlier from Jiangsu gdk Biotechnology
- Announcement on Passing of the General Manager
- Full Text of 2025 Semi-annual Report
- Announcement on Resignation of Supervisor and By-election of Employee Representative Supervisor
- Announcement on Reply to Regulatory Inquiry Letter Regarding Information Disclosure of 2024 Annual Report
- Announcement on Resolution of the 2024 Annual General Meeting
Later from Jiangsu gdk Biotechnology
- Announcement on Appointment of General Manager and Adjustment to the Members in the Audit Committee of Board of Directors
- Announcement on Abnormal Fluctuations in Stock Trading
- Announcement on Resignation of Securities Affairs Representative
- Earnings Preannouncement for 2025
- Announcement on Preliminary Earnings Estimate for 2025
Follow Jiangsu gdk Biotechnology into a list and get an email when it puts out news.
Follow Jiangsu gdk Biotechnology